search
for
 About Bioline  All Journals  Testimonials  Membership  News


VITAE Academia Biomédica Digital
Centro de Análisis de Imágenes Biomédicas Computarizadas-CAIBC0
ISSN: 1317-987x
No. 32, 2007
Bioline Code: va07027
Full paper language: Spanish
Document type: Research Article
Document available free of charge

VITAE Academia Biomédica Digital, No. 32, 2007

 es Sedación Analgesia Con Midazolam Y Remifentanil Para Exodoncia Quirúrgica De Terceros Molares. Reporte De Una Serie De Casos.
Merchán, Alejandro Salazar

Resumen

En cincuenta pacientes propuestos para exodoncia de terceros molares con sedación intravenosa, se realizó un estudio prospectivo observacional sobre la combinación: midazolam y remifentanilo. Se administró un bolus inicial de midazolam de 0,01 a 0,02 mg/kg. 5 minutos antes y remifentanilo (0,1 µg/kg/min), en 10 minutos o hasta alcanzar un nivel de sedación de Ramsay de 2 a 3, infiltración local con lidocaína 2%. Resultados: Un grado de sedación 2-3 se consiguió en 6 ± 2 minutos. En 48 pacientes (88 %) la cirugía se llevó a cabo con remifentanilo exclusivamente. Los efectos adversos fueron: nauseas postoperatorias 6%; hipotensión 2%. Rescate con propofol: 4%. Satisfacción para el cirujano: muy buena o excelente: 82%. Satisfacción para el paciente: Excelente o muy buena 98%.

Palabras-clave
remifentanilo, cirugía de terceros molares, sedación, analgesia.

 
 en Sedation Analgesia with Midazolan and Remifentanil in surgical exodoncy of the third molar. Report of a series
Merchán, Alejandro Salazar

Abstract

A Prospective, observational study was made on the use of remifentanil during third molar surgery. . Fifty patients were subjected to oral surgery under intravenous sedation. Midazolam 0,01 -0,02 mg/kg I.V. 5 minutes prior to remifentanil perfusion (0,01 µg/kg/min ) during 10 minutes or until reaching sedation score 2 or 3 on the Ramsay scale, followed by local infiltration with lidocaine 2%. A sedation grade 2-3 was achieved in 6 ± 2 minutes. In 48 patients (88%), the surgical procedure was performed only with remifentanil. Frequency of adverse events were: postoperative nausea 6%, hypotension 2%. In 4% of patients propofol was required as additional medication. Satisfaction score as evaluated by the performing surgeon was: excellent and very good (S&VG) 82%. Satisfation as evaluated by the patient was: S&VG 98%. Conclusions: Remifentanil is useful as third molar surgery sedoanalgesia method. Serious undesired effects are rare. Further studies are necessary to completely establish its effectiveness and safety in these types of procedures.

Keywords
remifentanil, third molar surgery, sedation, analgesia

 
© Copyright 2007 - Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO, Instituto de Medicina Tropical - Facultad de Medicina, Universidad Central de Venezuela
Alternative site location: http://vitae.ucv.ve

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil